Infosys Ltd Share Price

Overview

Infosys Ltd share price is currently ₹1,018.87, down by - ₹54.43 (5.07%) from its previous closing price of ₹1,073.30. The share price has declined -13.27% over the past month and declined -30.27% over the past year. The stock's 52-week low and high are ₹0.00 and ₹1,698.52, respectively. Infosys Ltd has a market capitalisation of ₹ 4,60,000.00 Cr. The share price was last updated on 09 Sep 2026, 01:07 PM IST.

Infosys Ltd
Infosys Ltd
INFY
 0.00
- 54.43
5.07%
IT
 0.00(%)1D

Updated: 09 Sep 2026, 01:07:27 pm IST

Market Data

Open Price

 1,065.94

Prev. Close

 1,073.30
 1,017.27

Day Low

 1,065.94

Day High

 0.00

52 Week Low

 1,698.52

52 Week High

ITIT - Software
CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

13.70

Sector PE

21.48

PB Ratio

4.52

Sector PB

1.90

EPS

74.37

Dividend Yield

3.84

Today's Volume

7.963 M

5 Day Avg. Volume

6.672 M

PEG Ratio

1.06

Market Cap.

₹ 4,60,000.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 500% at ₹25/Share
10-Jun-202610-Jun-2026
DividendsInterim Dividend of 460% at ₹23/Share
27-Oct-202527-Oct-2025
DividendsFinal Dividend of 440% at ₹22/Share
30-May-202530-May-2025
DividendsInterim Dividend of 420% at ₹21/Share
29-Oct-202429-Oct-2024

Mutual Fund Ownership

Mutual Fund Holder
Jul 26
Shares held
Aug 26
Shares held
UTI Nifty 50 ETF2.30 Cr
2.33 Cr
(1.4%)
UTI BSE Sensex ETF2.15 Cr
2.18 Cr
(1.62%)
UTI Nifty 50 Index Fund - Regular Plan - IDCW92.79 Lac
93.85 Lac
(1.15%)
UTI Large Cap Fund - Regular Plan - IDCW47.15 Lac
37.56 Lac
(20.34%)
UTI Value Fund - Regular Plan - Growth28.50 Lac
28.50 Lac
no change

About Infosys Ltd 👋

Infosys Limited is an India-based company which provides digital services and consulting. The Company enables clients in approximately 63 countries to navigate their digital transformation powered by cloud and artificial intelligence (AI). Its segments include Financial Services; Retail; Communication; Energy, Utilities, Resources and Services; Manufacturing; Hi-Tech; Life Sciences, and All other segments. The Company's solutions have been primarily classified as digital and core. Its digital solutions include experience, insight, innovate, accelerate, and assure. Its experience solutions include Infosys Aster, Digital Marketing, Digital Commerce and Infosys Metaverse Foundry. Its insight solutions include Infosys Topaz, Infosys Generative AI Labs, Data Analytics and AI, Infosys Sustainability Services and Applied AI. Its core solutions include application management services, proprietary application development services, traditional enterprise application implementation and others.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Chahat Aggrawal

Chahat Aggrawal

9 Sep • 12:02 PM · SEBI-Registered Analyst

Infosys Foundation Grants ₹31 Crore to Medical College

INFY
Foundation has announced a ₹31 crore grant to Madras Medical College on September 9, 2026. The funding will support the establishment of specialised cardio-obstetric care facilities at Rajiv Gandhi Government General Hospital in Chennai. The initiative aims to strengthen healthcare infrastructure and provide dedicated cardiac care support for women during pregnancy and the post-pregnancy period. The grant represents a significant contribution toward expanding specialised medical facilities and improving access to advanced healthcare services. The project also highlights Infosys Foundation’s continued focus on supporting healthcare and social development initiatives through institutional partnerships. Investors and stakeholders will track the implementation of the project and the impact of the new facilities on specialised healthcare delivery in the region.

See More
Inderjeet Singh

Inderjeet Singh

9 Sep • 10:27 AM · SEBI-Registered Analyst

IT Shares Fall for 6th Session; Coforge, Infosys, TCS Slide

TCS
stocks remained under pressure for the sixth straight session, with Coforge, Infosys and TCS among the major laggards. The sell-off was driven by broader market weakness, rising crude oil prices and renewed concerns over US interest rates, while Coforge faced additional pressure after its chairman resigned following concerns raised by an internal audit. The Nifty IT index fell around 3%, with Coforge declining as much as 6% in early trade. Coforge Chairman Om Prakash Bhatt resigned with immediate effect after an internal audit raised concerns regarding the company's board evaluation process. The development added to investor concerns around corporate governance and leadership stability. Broader macro concerns also weighed on the sector. Brent crude moved towards $100 per barrel amid escalating Middle East tensions, raising concerns over inflation and the possibility of tighter US monetary policy. Since Indian IT companies generate a significant portion of their revenue from overseas markets, renewed US rate-hike expectations have added to the cautious sentiment around technology stocks.

See More
Hruthik N

Hruthik N

9 Sep • 9:59 AM · SEBI-Registered Analyst

Today's Opening- Weak Start, IT & Banking Under Pressure

The market opened weak today, Sensex fell around 500 points, Nifty slipped below 23,550 in early trade. IT and banking stocks led the selling, with Infosys and SBI among the decliners, while ONGC and Adani Enterprises bucked the trend and opened higher. This comes on a day when six mainboard IPOs (Rentomojo, Asset Reconstruction Company India, Manipal Payment & Identity Solutions, Steamhouse India, LCC Projects, Karamtara Engineering) are opening for subscription simultaneously- a rare event pulling investor liquidity toward the primary market, which could be adding to the soft tone in secondary market trade. Pharma stock to watch:

BIOCON
Biocon is flagged as one of the stocks in focus today per CNBC-TV18's list of names likely to see action this session, alongside Bank of Baroda, TCS, Raymond, and Great Eastern Shipping. It closed marginally higher (+₹0.90) in yesterday's session. I'll be upfront here - I don't have a confirmed, specific catalyst for why Biocon is in focus today beyond its inclusion in that watchlist. Historically the stock has moved on USFDA inspection outcomes, biosimilars approvals, and its ongoing biologics consolidation story (post the Viatris stake buyout), so any fresh regulatory or business update could be the driver, I'd recommend checking a live source like NSE before treating this as a strong signal.

See More
SASI KUMAR SEBI RA

SASI KUMAR SEBI RA

9 Sep • 8:13 AM · SEBI-Registered Analyst

Pre Market Report & Global Cues | 09 September

Global cues are weak this morning. US markets closed in the red. Dow fell 1.18%, S&P 0.58%, and Nasdaq 0.32%. The main reason is strong US job data (162K vs 53K expected), which has again increased the chances of a rate hike. Because of this, the US 10Y yield is holding near 4.79%, and that is keeping pressure on global markets. Crude oil is the bigger concern right now. Brent is close to $99.5 after fresh tensions in West Asia and issues around the Strait of Hormuz. For India, this is clearly negative as it affects inflation and keeps pressure on the rupee. There is also some global uncertainty after Canada imposed tariffs on US goods, which is adding to the cautious sentiment. Asian markets are mixed. Kospi is up around 1.6%, but Hang Seng and Straits Times are slightly weak. Because of this, Gift Nifty is indicating a flat to slightly positive start. On the domestic side, India 10Y yield is around 6.95%, which is still on the higher side. The rupee has weakened to 94.8, showing pressure due to rising crude. Nifty closed at 23,635 in the previous session and the overall trend still looks weak. Even if we open flat, the market needs strong buying to turn positive. One more thing to note: ADRs were weak: Infosys, Wipro, HDFC Bank and ICICI Bank all saw selling. So IT and banking stocks may start the day under pressure. There will be stock-specific action as well. On the positive side, Enviro Infra has won a ₹190 Cr order, TCS secured a government deal, and NLC India got a 200 MW wind project. Raymond is also in focus after approving a fund raise. On the negative side, Moschip may see pressure due to a legal issue, while Biocon and Sanofi India may remain volatile due to ongoing developments. Sector-wise: Oil-sensitive sectors like aviation, paints and tyres may remain under pressure due to high crude. IT stocks may stay weak after the ADR fall. Capital goods and infra may see stock-specific buying.

See More
DEEPAK PAL

DEEPAK PAL

9 Sep • 5:56 AM · SEBI-Registered Analyst

PRE MARKET--> MARKETS NEAR AT LAST SUPPORTS BUT IT STOCKS..!

भारतीय बाजार के लिए आज का Pre-Market Setup काफी cautious नजर आ रहा है। GIFT Nifty कमजोर है, Crude Oil elevated levels पर बना हुआ है और U.S. markets हल्की कमजोरी के साथ बंद हुए हैं। इसके ऊपर Infosys ADR में करीब 4.9% की तेज गिरावट ने Indian IT stocks पर दबाव बढ़ा दिया है। लेकिन एक interesting factor भी है — Nifty और Bank Nifty दोनों का PCR काफी नीचे आ चुका है, जिससे market positioning काफी cautious हो गई है। @@Crude Oil बना सबसे बड़ा Risk Crude Oil अब $100 के बेहद करीब पहुंच गया है। Brent करीब $99/barrel तक पहुंचा है, जबकि geopolitical tensions ने oil prices को support दिया है। ##IT Stocks पर बढ़ा Pressure U.S. market में software stocks पर AI disruption की चिंता बनी हुई है। इसके साथ Infosys ADR करीब 4.87% गिरकर $11.13 पर बंद हुआ। Wipro और दूसरे Indian IT ADRs में भी कमजोरी ने sentiment को प्रभावित किया है। आज नजर रहेगी: •

INFY
• Wipro • TCS • HCLTech • Tech Mahindra $$FII / DII Activity — 8 September 2026 ( NEUTRAL ) Cash Market • FII: -₹123.19 करोड़ • DII: +₹1,349.64 करोड़ FII Derivatives • Index Futures: -₹1,822.58 करोड़ • Index Options: +₹17,952.86 करोड़ • Stock Futures: -₹427.91 करोड़ • Stock Options: +₹151.11 करोड़ ------>PCR काफी नीचे — क्या Market Oversold Zone में? Nifty PCR: 0.61 Bank Nifty PCR: 0.89 PCR 0.61 और 0.89 relatively low levels हैं और options positioning में bearish/cautious bias दिखाते हैं। लेकिन ध्यान रखें: Low PCR = automatically market bottom नहीं। अगर selling के बाद support टूटता है, तो low PCR के बावजूद downside जारी रह सकता है। हालांकि, इतनी cautious positioning के बाद अगर बाजार अचानक मजबूत होता है, तो short covering तेज recovery भी करा सकती है। ##Bank Nifty: 57,000 सबसे अहम Level Bank Nifty के लिए: 57,000 = Major Support 57,000 के ऊपर टिकाव: Recovery और short covering की संभावना 57,000 के नीचे breakdown: Selling pressure और बढ़ सकता है ##Metals फिर दिखा रहे Relative Strength जहां IT और Banking पर pressure है, वहीं Metals लगातार बेहतर प्रदर्शन कर रहे हैं।

See More
Shree Dhanraksha Securities

Shree Dhanraksha Securities

8 Sep • 7:39 PM · SEBI-Registered Analyst

Global macroeconomic risk enters Indian portfolios

INFY
was among the biggest Nifty losers on 7 September, falling 3.76%, while the Nifty IT index declined 2.28%. Reuters also reported that Indian IT stocks came under pressure as concerns over oil prices and geopolitical tensions combined with changing expectations around US monetary policy. This provides a critical lesson for beginners: an Indian IT company's business may depend heavily on the United States and other developed economies. Therefore, investors should monitor US technology spending, recession risks, interest rates, currency movements, artificial intelligence disruption and large-deal wins. Investor lesson: An Indian company's stock can be strongly affected by events occurring thousands of kilometres away.

See More

News & Events

Frequently Asked Questions

What is the share price of Infosys Ltd?

What is the market cap of Infosys Ltd?

Should I buy Infosys Ltd stock now?

What is the 52 week high and low of Infosys Ltd?

Is the Infosys Ltd stock good to buy?

Is Infosys Ltd a good buy for the long term?

Is Infosys Ltd overvalued or undervalued?

What is the PE and PB ratio of Infosys Ltd?

Start Now